Uriclarity Program's effect on milk supply perception in new mothers
Effect of the Uriclarity Program on the Perception of Insufficient Milk Supply in Postpartum Women From Three Hospitals in Piura-Peru Evaluated Through a Randomized Controlled Trial
This study tests if the Uriclarity Program, which offers training and support, can help new mothers in Peru feel more confident about their milk supply compared to regular lactation counseling.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Crianzamor Academic / other |
| Locations | 2 sites (Piura, Chulucanas and 1 other locations) |
| Trial ID | NCT06857461 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of the Uriclarity Program in reducing perceived insufficient milk supply (PIM) among postpartum women in Piura, Peru. Participants will be randomly assigned to receive either the Uriclarity Program, which includes hands-on training and WhatsApp support, or standard lactation counseling. The study will assess changes in PIM scores at multiple postpartum intervals using a validated questionnaire. The aim is to enhance breastfeeding confidence and adherence to exclusive breastfeeding practices.
Who should consider this trial
Good fit: Ideal candidates are postpartum women within 24-48 hours after delivery with term infants who are exclusively breastfeeding.
Not a fit: Patients with conditions affecting breastfeeding or those who have used formula or pacifiers prior to enrollment may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve breastfeeding outcomes and maternal confidence for new mothers experiencing perceived insufficient milk supply.
How similar studies have performed: While the Uriclarity Program is a novel approach, similar interventions focusing on lactation support have shown promise in improving breastfeeding outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Postpartum women within 24-48 hours after delivery (vaginal or cesarean). * Term neonates (37-41 weeks of gestation). * Exclusive breastfeeding at enrollment. * Maternal education level of at least primary school completed. * Ability to use a smartphone with WhatsApp for follow-up support. Exclusion Criteria: * Maternal conditions that may affect breastfeeding, such as flat or inverted nipples, diabetes, hypertension, or morbid obesity. * Maternal medication with effects on lactation. * Cigarette smoking. * Neonatal conditions impacting breastfeeding, including congenital heart defects, cleft lip/palate, or ankyloglossia. * Use of infant formula, pacifiers, or bottles before enrollment. * Diagnosed maternal or neonatal illness after study enrollment that may interfere with breastfeeding. * Newborns who experienced hypoglycemia, weight loss equal to or greater than 7%, or any condition related to breastfeeding failure during their hospital stay.
Where this trial is running
Piura, Chulucanas and 1 other locations
- Hospital de Chulucanas — Piura, Chulucanas, Peru (Recruiting)
- Crianzamor — Piura, Peru (Not_yet_recruiting)
Study contacts
- Principal investigator: Jackeline Ashiyama Vega, NP — Crianzamor
- Study coordinator: Javier H Ravichagua Ashiyama, MD
- Email: javier.ravichagua.a@upch.pe
- Phone: +51 923 595 529
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.